Confident Investing Starts With TipRanks Premium

Get 55% Off
TipRanks
Go Ultimate55% OFF

Jeffrey Hatfield Insider Profile

4 Followers

Jeffrey Hatfield, Director at Vir Biotechnology, holds 39.81K shares in Vir Biotechnology (Ticker: VIR), holds ― shares in Invivo Therapeutics Holdings (Ticker: NVIVQ), holds ― shares in Larimar Therapeutics (Ticker: LRMR).

Jeffrey Hatfield's Trading History

VIRVir Biotechnology		May 28, 2026DirectorUninformative Buy―$449.81K
VTAEVitae Pharma		Oct 25, 2016―Uninformative Sell5.14M$6.17M
~AMBIAmbit		――――
ATYRaTyr Pharma		―Director――
VRDNViridian Therapeutics		―Director――
LRMRLarimar Therapeutics		―CEO, Director――
NVIVQInvivo Therapeutics Holdings		――――
See All Insider Trading from Today

You May Also Like

Meet our Smart Portfolio. See what top analysts say about your stocks.Get a breakdown of the different strategies based on detected insider trading activity.Find the best performing Analyst in each sector. Follow them so you never miss a recommendation.

Jeffrey Hatfield insider profile FAQ

What is the percentage of profitable transactions made by Jeffrey Hatfield?
The percentage of profitable transactions made by Jeffrey Hatfield is 0%.
What is the average return per transaction made by Jeffrey Hatfield?
The average return per transaction made by Jeffrey Hatfield is -44.60%.
What stocks does Jeffrey Hatfield hold?
Jeffrey Hatfield holds: VIR, NVIVQ, LRMR, VRDN, VTAE, ATYR, ~AMBI stocks.
What was Jeffrey Hatfield's most profitable transaction?
Jeffrey Hatfield’s most profitable transaction was an Informative Buy of VTAE stock on January 26, 2015. The return on the trade was -32.90%.
What is Jeffrey Hatfield's role in Vir Biotechnology?
Jeffrey Hatfield's role in Vir Biotechnology is Director.
How can I follow the stock ratings of top corporate insiders?
Head over to our Expert Center to see a list of the Top 100 corporate insiders and follow the corporate insiders of your choice. Visit their profiles for more details about their stock transactions and see how they perform on a stock-by-stock basis.

TipRanks measures corporate insiders by the stock transactions they report to the SEC. See how TipRanks ranks experts and calculates performance.